NERV - Minerva Neurosciences, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Annual

Cash Flow

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
12/30/2015
Cash flows from operating activities
Net Income
-53,527
-50,171
-31,523
-31,045
-27,082
Depreciation & amortization
88
17
11
17
17
Deferred income taxes
-
0
-9,376
-
-
Stock based compensation
8,953
8,183
5,033
3,571
2,202
Change in working capital
5,508
111
38,927
1,320
-32
Accounts receivable
-
-
-
-
-
Inventory
-
-
-
-
-
Accounts Payable
-
364
-33
108
719
Other working capital
-39,515
-41,942
3,040
-25,688
-24,269
Other non-cash items
1
38
-
4,022
2,827
Net cash provided by operating activites
-39,515
-41,942
3,093
-25,688
-24,269
Cash flows from investing activities
Investments in property, plant and equipment
-
-
-52
-
-
Acquisitions, net
-
-
-
-
-
Purchases of investments
-65,912
-40,661
-134,526
0
-23,279
Sales/Maturities of investments
64,800
110,151
27,390
17,818
4,995
Other investing activites
-
-
-
0
-45
Net cash used for investing activites
-1,112
69,490
-107,188
17,818
-18,330
Cash flows from financing activities
Debt repayment
-1,398
-4,001
-4,939
-1,571
-
Common stock issued
-
0
44,563
58,500
31,000
Common stock repurchased
-
0
0
-
-
Dividends Paid
-
-
-
-
-
Other financing activites
-
-
-2,944
-3,832
-2,663
Net cash used privided by (used for) financing activities
-217
-3,345
47,167
76,566
38,337
Net change in cash
-40,844
24,203
-56,929
68,697
-4,262
Cash at beginning of period
68,789
26,132
82,981
14,284
18,546
Cash at end of period
27,945
50,335
26,052
82,981
14,284
Free Cash Flow
Operating Cash Flow
-39,515
-41,942
3,093
-25,688
-24,269
Capital Expenditure
-
-
-52
-
-
Free Cash Flow
-39,515
-41,942
3,040
-25,688
-24,269